RESUMO
The primary structure of the second transmembrane (M2) segment of resistant to dieldrin (RDL), an ionotropic γ-aminobutyric acid receptor (GABAR) subunit, and the structure-function relationships in RDL are well conserved among insect species. An amino acid substitution at the 2' position in the M2 segment (Ala to Ser or Gly) confers resistance to non-competitive antagonists (NCAs) of GABARs. Here, a cDNA encoding RDL was cloned from the two-spotted spider mite Tetranychus urticae Koch. Unlike insect homologs, native TuRDL has His at the 2' position (H305) and Ile at 6' (I309) in the M2 segment and is insensitive to NCAs. Single and multiple mutations were introduced in the M2 segment of TuRDL, and the mutant proteins were expressed in Xenopus oocytes and examined for the restoration of sensitivity to NCAs. The sensitivity of a double mutant (H305A and I309T in the M2 segment) was greatly increased but was still considerably lower than that of insect RDLs. We therefore constructed chimeric RDLs consisting of TuRDL and Drosophila melanogaster RDL and examined their sensitivities to NCAs. The results show that the N-terminal region containing the Cys-loop as well as the M2 segment confers functional specificity; thus, our current understanding of the mechanism underlying NCA binding to GABARs requires reappraisal.
Assuntos
Canais de Cloreto/genética , Proteínas de Drosophila/química , Receptores de GABA-A/química , Tetranychidae/genética , Ácido gama-Aminobutírico/farmacologia , Sequência de Aminoácidos , Animais , Afídeos , Brassica , Canais de Cloreto/metabolismo , Relação Dose-Resposta a Droga , Proteínas de Drosophila/genética , Drosophila melanogaster , Resistência a Medicamentos/efeitos dos fármacos , Resistência a Medicamentos/genética , Feminino , Masculino , Phaseolus , Estrutura Secundária de Proteína , Receptores de GABA-A/genética , Tetranychidae/efeitos dos fármacos , Xenopus laevis , Ácido gama-Aminobutírico/metabolismoRESUMO
The last few years have seen the introduction of an unprecedented number of new classes of acaricides with novel or under-exploited modes of action, discovered by traditional screening. Acaricide research has uncovered several unrelated compounds that possess improved properties. Pyridaben, acequinocyl, diafenthiuron, etoxazole, spirodiclofen and bifenazate, in particular, are acaricides that are safe to beneficials, have low mammalian toxicity and short environmental persistence. Many of the new acaricides appear to affect mitochondrial respiration, and previously unknown targets affecting mite growth and development have been identified, offering new opportunities for mite control.
Assuntos
Inseticidas/farmacologia , Ácaros , Animais , Inseticidas/química , Ácaros/crescimento & desenvolvimento , Ácaros/metabolismo , Estrutura Molecular , Sistema Nervoso/efeitos dos fármacos , Relação Estrutura-AtividadeRESUMO
Bifenazate is a very selective acaricide that controls the spider mite, Tetranychus urticae. Bifenazate is the first example of a carbazate acaricide. Its mode of action remains unclear. Bifenazate and its active metabolite diazene induce paralysis in spider mites, suggesting that they may act on the nervous system. Here we have employed a homologue (TuGABAR) of RDL (Resistance to dieldrin), a subunit of ionotropic γ-aminobutyric acid (GABA) receptor, from T. urticae to investigate the action of bifenazate and its active metabolite diazene on this receptor function. Although neither acaricide showed a GABA agonist action, 30 µM of bifenazate or diazene significantly enhanced the GABA-induced response of TuGABAR in a dose-dependent manner, shifting the EC(50) of GABA from 24.8 µM to 4.83 µM and 10.8 µM, respectively. This action demonstrates a positive allosteric modulator effect of bifenazate on T. urticae GABA receptors. This synergistic action is likely the result of bifenazate binding to a site distinct from that of the GABA binding site causing a conformational change that affects the magnitude of the GABA response. Precisely how the observed GABA synergist action correlates with the acaricidal activity of bifenazate, if at all, has yet to be determined.